Danaher Corporation $DHR Holdings Trimmed by Foresight Group Ltd Liability Partnership

Foresight Group Ltd Liability Partnership trimmed its holdings in shares of Danaher Corporation (NYSE:DHR) by 49.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 27,893 shares of the conglomerate’s stock after selling 27,564 shares during the period. Foresight Group Ltd Liability Partnership’s holdings in Danaher were worth $5,530,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. White Pine Capital LLC increased its stake in shares of Danaher by 1.4% during the 2nd quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock worth $690,000 after purchasing an additional 49 shares during the last quarter. SOL Capital Management CO boosted its holdings in Danaher by 2.8% in the third quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate’s stock worth $363,000 after purchasing an additional 50 shares in the last quarter. Purkiss Capital Advisors LLC boosted its holdings in Danaher by 3.9% in the third quarter. Purkiss Capital Advisors LLC now owns 1,327 shares of the conglomerate’s stock worth $263,000 after purchasing an additional 50 shares in the last quarter. Boyd Watterson Asset Management LLC OH increased its position in Danaher by 2.1% during the second quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock worth $499,000 after buying an additional 51 shares during the last quarter. Finally, Howard Capital Management Group LLC raised its holdings in Danaher by 4.8% during the third quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate’s stock valued at $230,000 after buying an additional 53 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the transaction, the senior vice president directly owned 14,553 shares of the company’s stock, valued at $3,190,454.19. This trade represents a 59.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Teri List sold 3,298 shares of Danaher stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the transaction, the director owned 20,762 shares in the company, valued at $4,702,593. This trade represents a 13.71% decrease in their position. The disclosure for this sale is available in the SEC filing. 11.20% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Jefferies Financial Group increased their price objective on Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Argus set a $265.00 target price on Danaher in a research report on Wednesday, January 14th. Wells Fargo & Company lifted their price target on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a research report on Monday, December 15th. Leerink Partners boosted their price objective on shares of Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Danaher in a report on Thursday, January 29th. Twenty equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $253.86.

Danaher Stock Up 0.0%

Shares of NYSE DHR opened at $216.65 on Tuesday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The business has a fifty day moving average of $229.47 and a two-hundred day moving average of $215.27. The stock has a market cap of $153.03 billion, a PE ratio of 42.99, a PEG ratio of 2.93 and a beta of 0.91.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 28th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.09. The firm had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.14 EPS. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. As a group, equities research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s dividend payout ratio (DPR) is currently 25.40%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.